87153-04-6

Basic information

• Product Name: 3,4-DIHYDRO-6-[4-[1-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-TETRAZOL-5-YL]BUTOXY]-2(1H)-QUINOLINONE
• Synonyms: 3,4-DIHYDRO-6-[4-[1-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-TETRAZOL-5-YL]BUTOXY]-2(1H)-QUINOLINONE;OPC-13213(TRANS);4trans-Hydroxy Cilostazol;OPC 13213;trans-3,4-Dihydro-6-[4-[1-(4-hydroxycyclohexyl)-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone;OPC-13213(trans): 3,4-dihydro-6-[4-[1-(trans-4-hydroxycyclohexyl)-1H-tetrazol-5-yl]butoxy]-2(1H)-Quinolinone
• CAS NO: 87153-04-6
• Molecular Formula: C₂₀H₂₇N₅O₃
• Molecular Weight: 385.46
• Product Categories: Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals
• Mol File: 87153-04-6.mol
• Article Data: 2

Chemical Properties

• Melting Point: 200-202°C
• Boiling Point: 710.5°C at 760 mmHg
• Flash Point: 383.5°C
• Appearance: /
• Density: 1.42g/cm³
• Vapor Pressure: 3.46E-21mmHg at 25°C
• Refractive Index: 1.691
• Storage Temp.: -20°C Freezer
• PKA: 14.22±0.20(Predicted)
• CAS DataBase Reference: 3,4-DIHYDRO-6-[4-[1-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-TETRAZOL-5-YL]BUTOXY]-2(1H)-QUINOLINONE(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-DIHYDRO-6-[4-[1-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-TETRAZOL-5-YL]BUTOXY]-2(1H)-QUINOLINONE(87153-04-6)
• EPA Substance Registry System: 3,4-DIHYDRO-6-[4-[1-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-TETRAZOL-5-YL]BUTOXY]-2(1H)-QUINOLINONE(87153-04-6)

Safety Data

• Hazardous Substances Data: 87153-04-6(Hazardous Substances Data)

Usage

Description

3,4-DIHYDRO-6-[4-[1-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-TETRAZOL-5-YL]BUTOXY]-2(1H)-QUINOLINONE is a complex organic compound with a unique molecular structure. It is characterized by a quinolone core, with a 3,4-dihydro and 6-hydroxy group attached. The molecule also contains a trans-4-hydroxycyclohexyl tetrazole moiety and a butoxy group, which contribute to its chemical properties and potential applications.

Uses

Used in Pharmaceutical Industry:
3,4-DIHYDRO-6-[4-[1-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-TETRAZOL-5-YL]BUTOXY]-2(1H)-QUINOLINONE is used as a pharmaceutical compound for its potential therapeutic effects. Its unique structure allows it to interact with biological targets, making it a promising candidate for the development of new drugs.
Used in Chemical Research:
3,4-DIHYDRO-6-[4-[1-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-TETRAZOL-5-YL]BUTOXY]-2(1H)-QUINOLINONE is also used in chemical research for its unique properties and potential applications. Researchers can study its chemical behavior and interactions with other molecules to gain insights into its potential uses and develop new applications.
Used as a Labelled Metabolite:
3,4-DIHYDRO-6-[4-[1-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-TETRAZOL-5-YL]BUTOXY]-2(1H)-QUINOLINONE can be used as a labelled metabolite in various analytical techniques. Its unique structure and properties make it suitable for tracking and analyzing metabolic pathways, which can be useful in both research and clinical settings.
Chemical Properties:
3,4-DIHYDRO-6-[4-[1-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-TETRAZOL-5-YL]BUTOXY]-2(1H)-QUINOLINONE is a white to off-white solid, indicating its stability and potential for use in various applications. Its solid-state properties can be further studied to understand its behavior in different environments and its interactions with other compounds.

InChI:InChI=1/C20H27N5O3/c26-16-7-5-15(6-8-16)25-19(22-23-24-25)3-1-2-12-28-17-9-10-18-14(13-17)4-11-20(27)21-18/h9-10,13,15-16,26H,1-8,11-12H2,(H,21,27)/t15?,16-

Upstream product

• 98454-50-3 1-(trans-4-benzyloxycyclohexyl)-5-(4-chlorobutyl)-1H-tetrazole 
• 54197-66-9 3,4-dihydro-6-hydroxy-2(1H)-quinolinone 
• 87152-97-4 6-(4-<1-(trans-4-benzyloxycyclohexyl)-1H-5-tetrazolyl>butoxy)-2-oxo-1,2,3,4-tetrahydroquinoline 
• 73963-72-1 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril 

Relevant articles and documents

Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. IV. Synthesis and biological activity of the metabolites of 6-[4-(1-cyclohexyl-1H-5-tetrazolyl)butoxy]-2-oxo-1,2,3,4- tetrahydroquinoline (OPC-13013)

-